Company Filing History:
1 out of 639 
1 out of 43 
Years Active: 2020
Title: Julie Demaret: Innovator in Risk Evaluation for Sepsis
Introduction
Julie Demaret, based in Lyons, France, is a notable inventor recognized for her contributions to the medical field. With a single patent to her name, she has made significant strides in understanding the prognosis for patients suffering from systemic inflammatory response syndrome (SIRS) or sepsis.
Latest Patents
Her patented invention is titled "Method for evaluating the risk of mortality in patients who exhibit a systemic inflammatory response syndrome (SIRS) or sepsis." This innovative method enhances the evaluation process by measuring the expression of sCD127 in biological samples, offering a more precise assessment of patient mortality risks.
Career Highlights
Julie has held pivotal roles in esteemed organizations, including bioMérieux, Inc., and Hospices Civils de Lyon. Her work at these institutions has provided her with a platform to delve deeply into the complexities of inflammatory responses and their implications for patient care.
Collaborations
Throughout her career, Julie has collaborated with distinguished colleagues such as Guillaume Monneret and Fabienne Venet. These partnerships reflect her commitment to advancing medical research and improving patient outcomes through innovative methodologies.
Conclusion
In summary, Julie Demaret exemplifies the spirit of innovation in the medical field. Her patent on evaluating mortality risk in patients demonstrates her dedication to enhancing healthcare practices. As research and development continue to evolve, inventors like Julie play a crucial role in shaping the future of medicine.